Antengene-B (06996) has announced that Mr. Long Zhenguo has resigned as Executive Director and Chief Financial Officer of the company, effective August 1, 2026, to pursue other career development opportunities.
Dr. Hou Bing has been appointed as an Executive Director, effective August 1, 2026. Ms. Guo Rui has been appointed as the company's Chief Business Officer, also effective from August 1, 2026.
Following Mr. Long's resignation as Executive Director, he will also cease to serve as the company's authorized representative under Rule 3.05 of the Listing Rules, as well as the company's authorized representative for receiving service of process and notices in Hong Kong under Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong) and Rule 19.05(2) of the Listing Rules, all effective from August 1, 2026. Dr. Hou has been appointed as the authorized representative, effective August 1, 2026. Additionally, Mr. Qiu Yijun has been appointed as the process agent, effective August 1, 2026.